Lakefront Biotherapeutics | GLPG - Passività Correnti





Passività Correnti Cambiamento Data
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Biogen USD 3.92B 918.2M 2026-06
Genmab DKK 1.14B 38M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
GRIFOLS EUR 2.24B 112M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Incyte USD 1.31B 177.55M 2026-06
Merck EUR 8.12B 1.22B 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novartis USD 31.75B 374M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
UCB EUR 4.4B 470M 2025-12
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06